Skip to content

Human Breastmilk in Young Children With Norovirus Infection of the Gut

A Pilot Study of Enteral Donor Human Milk in Young Children With Norovirus Infection of the Gut

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02371538
Enrollment
4
Registered
2015-02-25
Start date
2014-10-31
Completion date
2016-07-02
Last updated
2020-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Norovirus Infections

Keywords

stem cell transplant, human breastmilk

Brief summary

Human Breast milk in young children with Norovirus Infection

Detailed description

The investigators hypothesize that children with clinically significant norovirus infection of the gut who receive enteral human milk will more successfully clear the virus or experience improved symptoms compared to children not receiving human milk.

Interventions

DIETARY_SUPPLEMENTDonor Breastmilk

Donor breastmilk will be obtained from the Mother's Milk Bank of New England.

Sponsors

Mothers' Milk Bank Northeast
CollaboratorOTHER
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Children with at least two stool samples taken at least 7 days apart that are positive for norovirus * Child has an underlying disease or has received immunosuppressive medication or chemotherapy such that clearance of norovirus is expected to be impaired.

Exclusion criteria

* The presence of other pathogens causing diarrhea that have specific treatments does not preclude enrollment. However, specific treatment should be offered in addition to human milk.

Design outcomes

Primary

MeasureTime frameDescription
Loose/Unformed/Liquid Stools or Abdominal CrampingUp to 12 weeksEpisodes or number of days of loose/unformed/liquid stools or abdominal cramping will be reported.
NorovirusUp to 12 weeksStool samples will be tested for the presence of norovirus.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026